106 related articles for article (PubMed ID: 8093903)
1. Detection of the extracellular domain of c-erbB-2 oncoprotein in sera from patients with various carcinomas: correlation with tumor markers.
Wu JT; Astill ME; Zhang P
J Clin Lab Anal; 1993; 7(1):31-40. PubMed ID: 8093903
[TBL] [Abstract][Full Text] [Related]
2. Measurement of c-erbB-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: correlation with serum tumor markers and membrane-bound oncoprotein.
Wu JT; Astill ME; Gagon SD; Bryson L
J Clin Lab Anal; 1995; 9(3):151-65. PubMed ID: 7541455
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer.
McKenzie SJ; DeSombre KA; Bast BS; Hollis DR; Whitaker RS; Berchuck A; Boyer CM; Bast RC
Cancer; 1993 Jun; 71(12):3942-6. PubMed ID: 8099528
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of serum ErbB-2 protein using enzyme immuno assay (ErbB-2 EIA [Nichirei])].
Sugano K; Kawai T; Ishii M; Koyama H; Kitajima M; Kasumi F; Demura R; Nakayama T; Okabe H; Mori S
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1255-62. PubMed ID: 7913313
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy.
Meden H; Marx D; Fattahi A; Rath W; Kron M; Wuttke W; Schauer A; Kuhn W
J Cancer Res Clin Oncol; 1994; 120(6):378-81. PubMed ID: 7908021
[TBL] [Abstract][Full Text] [Related]
6. The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage.
Pupa SM; Ménard S; Morelli D; Pozzi B; De Palo G; Colnaghi MI
Oncogene; 1993 Nov; 8(11):2917-23. PubMed ID: 8105438
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
[TBL] [Abstract][Full Text] [Related]
8. Low frequency and low level of elevation of serum CA 72-4 in human carcinomas in comparison with established tumor markers.
Wu JT; Carlisle P
J Clin Lab Anal; 1992; 6(1):59-64. PubMed ID: 1542085
[TBL] [Abstract][Full Text] [Related]
9. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
Li BD; Bauer KD; Carney WP; Duda RB
J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
[TBL] [Abstract][Full Text] [Related]
10. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.
Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G
J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study.
Suwanagool P; Parichatikanond P; Maeda S
Asian Pac J Allergy Immunol; 1993 Dec; 11(2):119-22. PubMed ID: 7915904
[TBL] [Abstract][Full Text] [Related]
12. [Sensitive enzyme immunoassay by using chemiluminescence for the determination of serum c-erbB-2].
Kaetsu T; Mogi Y; Kawamura M; Koike T; Ishizawa S; Fukuchi K; Takagi Y; Gomi K
Nihon Shokakibyo Gakkai Zasshi; 1991 Aug; 88(8):1622. PubMed ID: 1942620
[No Abstract] [Full Text] [Related]
13. Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans.
Brandt-Rauf PW; Luo JC; Carney WP; Smith S; De Vivo I; Milling C; Hemminki K; Koskinen H; Vainio H; Neugut AI
Int J Cancer; 1994 Feb; 56(3):383-6. PubMed ID: 7906254
[TBL] [Abstract][Full Text] [Related]
14. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.
Watanabe T; Fukutomi T; Tsuda H; Adachi I; Nanasawa T; Yamamoto H; Abe K
Jpn J Cancer Res; 1993 Dec; 84(12):1279-86. PubMed ID: 7904987
[TBL] [Abstract][Full Text] [Related]
15. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.
Breuer B; De Vivo I; Luo JC; Smith S; Pincus MR; Tatum AH; Daucher J; Minick CR; Miller DG; Nowak EJ
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):63-6. PubMed ID: 7906981
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of serum ErbB-2 protein using sandwich radioimmunometric assay (ErbB-2 IRMA 'Eiken')].
Sugano K; Kawai T; Ishii M; Koyama H; Kitajima M; Kasumi F; Demura R; Nakayama T; Okabe H; Mori S
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1245-53. PubMed ID: 7913312
[TBL] [Abstract][Full Text] [Related]
18. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
Meenakshi A; Kumar RS; Kumar NS
J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
[TBL] [Abstract][Full Text] [Related]
19. Isolation of the intact molecule and ectodomain of C-erbB-2 oncoprotein from SK-BR-3 cells and development of immunoassays on microplate.
Wu JT; Zhang P; Lyons BW; Wu LH
J Clin Lab Anal; 1998; 12(5):298-303. PubMed ID: 9773962
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]